Patent classifications
A61K8/20
TOOTHPASTE COMPOSITION
A toothpaste composition for tooth whitening comprising first contents and second contents, wherein one of the first contents and second contents comprises a tooth whitening agent, and it is constructed such that the first contents and second contents are filled in a container having a diaphragm or separate containers and simultaneously used when brushing teeth is provided. The container is a dip tube container.
READILY DISSOLVABLE CARTRIDGE COMPLEX AND INDUSTRIAL SYSTEMS AND PROCESSES OF FABRICATING THE SAME
An industrial process of fabricating a readily dissolvable cartridge complex is described; a respective industrial manufacture system and a cartridge complex are further described; the process comprises: preparing an effervescent material, forming at least one segment of a segmental scaffolding, preparing a payload substance, forming structured payload substance pellets, accommodating the structured payload substance pellets in the compartments of the segmental scaffolding, compressing segment of the segmental scaffolding, iteratively forming a plurality of segments of the readily dissolvable cartridge complex; the industrial manufacture system comprises: at least one form, a segmental scaffolding fabricating machine, a structured payload substance pellets fabricating machine; the readily dissolvable cartridge complex comprises: a segmental scaffolding, a plurality of radial partitions of the segmental scaffolding, a plurality of segments of said dissolvable cartridge complex, axial partitions of the segmental scaffolding, a plurality of compartments and a plurality of structured payload pellets.
READILY DISSOLVABLE CARTRIDGE COMPLEX AND INDUSTRIAL SYSTEMS AND PROCESSES OF FABRICATING THE SAME
An industrial process of fabricating a readily dissolvable cartridge complex is described; a respective industrial manufacture system and a cartridge complex are further described; the process comprises: preparing an effervescent material, forming at least one segment of a segmental scaffolding, preparing a payload substance, forming structured payload substance pellets, accommodating the structured payload substance pellets in the compartments of the segmental scaffolding, compressing segment of the segmental scaffolding, iteratively forming a plurality of segments of the readily dissolvable cartridge complex; the industrial manufacture system comprises: at least one form, a segmental scaffolding fabricating machine, a structured payload substance pellets fabricating machine; the readily dissolvable cartridge complex comprises: a segmental scaffolding, a plurality of radial partitions of the segmental scaffolding, a plurality of segments of said dissolvable cartridge complex, axial partitions of the segmental scaffolding, a plurality of compartments and a plurality of structured payload pellets.
Dimethylsiloxane-alkylene oxide copolymers
Copolymers are formed of monomers of poly(dimethylsiloxane) and poly(alkylene oxide) of the following formula: A.sub.x-XCH.sub.2CH.sub.2—[B.sub.yC.sub.z].sub.n—X-A.sub.x. In the formula, each X independently represents a —CH.sub.2— group or an oxygen atom, A represents a polydimethylsiloxane derivative, B represents a polyethylene glycol unit, C represents a polypropylene glycol unit, x and n independently represent an integer from 1 to 150, and y and z independently represent an integer from 0 to 150. The copolymers can be used as emulsifiers in personal care compositions.
Dimethylsiloxane-alkylene oxide copolymers
Copolymers are formed of monomers of poly(dimethylsiloxane) and poly(alkylene oxide) of the following formula: A.sub.x-XCH.sub.2CH.sub.2—[B.sub.yC.sub.z].sub.n—X-A.sub.x. In the formula, each X independently represents a —CH.sub.2— group or an oxygen atom, A represents a polydimethylsiloxane derivative, B represents a polyethylene glycol unit, C represents a polypropylene glycol unit, x and n independently represent an integer from 1 to 150, and y and z independently represent an integer from 0 to 150. The copolymers can be used as emulsifiers in personal care compositions.
TOOTH WHITENING METHOD
The present invention relates to a method for whitening teeth. The method for whitening teeth according to the present invention can promote the whitening activity of a tooth whitening agent and increase the degree of permeation of the whitening agent into the teeth, thereby obtaining an excellent whitening effect. Therefore, an excellent whitening effect can be obtained despite the use of low-concentration peroxide, compared with the use of high-concentration peroxide.
Compositions and methods for treating canker sores
Oral compositions and methods of use thereof are provided herein. The oral compositions comprise a first component comprising at least one E.sub.h-raising compound and a pharmaceutically acceptable carrier, and a second component comprising at least one zinc compound, an anti-microbial agent and a pharmaceutically acceptable carrier.
Compositions and methods for treating canker sores
Oral compositions and methods of use thereof are provided herein. The oral compositions comprise a first component comprising at least one E.sub.h-raising compound and a pharmaceutically acceptable carrier, and a second component comprising at least one zinc compound, an anti-microbial agent and a pharmaceutically acceptable carrier.
Laser assisted wound healing protocol and system
A method of treating diseased tissue while healing the wound using a diode laser which generates a beam of light having a wavelength in the visible portion of the electromagnetic spectrum (400 nm-700 nm) at a laser power of 0.001 to 1.2 watts, used with intermittent stops to control tissue temperature and biostimulate epithelial regeneration when used with or without substrates. A method of treating diseased tissue using a laser light in the green wavelength range (520-570 nm) at a laser power of 0.001 W to 5 W. A method of treating diseased tissue using a laser light in the IR wavelength range (700-1400 nm) at a laser power of 0.001 W to 5 W.
Laser assisted wound healing protocol and system
A method of treating diseased tissue while healing the wound using a diode laser which generates a beam of light having a wavelength in the visible portion of the electromagnetic spectrum (400 nm-700 nm) at a laser power of 0.001 to 1.2 watts, used with intermittent stops to control tissue temperature and biostimulate epithelial regeneration when used with or without substrates. A method of treating diseased tissue using a laser light in the green wavelength range (520-570 nm) at a laser power of 0.001 W to 5 W. A method of treating diseased tissue using a laser light in the IR wavelength range (700-1400 nm) at a laser power of 0.001 W to 5 W.